litlas
Log inCreate account

John M. Kane

Active 1980–2026

409
Papers
75,780
Citations
152
h-index
397
i10-index

Citations

Citations per year for John M. Kane1902: 1 citations1982: 2 citations1983: 7 citations1984: 10 citations1985: 14 citations1986: 25 citations1987: 25 citations1988: 21 citations1989: 35 citations1990: 51 citations1991: 67 citations1992: 77 citations1993: 103 citations1994: 72 citations1995: 98 citations1996: 103 citations1997: 138 citations1998: 137 citations1999: 211 citations2000: 189 citations2001: 162 citations2002: 186 citations2003: 255 citations2004: 242 citations2005: 412 citations2006: 447 citations2007: 499 citations2008: 517 citations2009: 483 citations2010: 517 citations2011: 471 citations2012: 461 citations2013: 397 citations2014: 338 citations2015: 354 citations2016: 394 citations2017: 463 citations2018: 525 citations2019: 1,839 citations2020: 1,868 citations2021: 1,847 citations2022: 1,446 citations2023: 1,102 citations2024: 1,883 citations2025: 893 citations2026: 85 citations1903–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,936 citing papers, 27.3% of this breakdownUnited Kingdom: 2,047 citing papers, 9.4% of this breakdownGermany: 1,329 citing papers, 6.1% of this breakdownCanada: 1,212 citing papers, 5.6% of this breakdownChina: 983 citing papers, 4.5% of this breakdownItaly: 936 citing papers, 4.3% of this breakdownAustralia: 932 citing papers, 4.3% of this breakdownSpain: 742 citing papers, 3.4% of this breakdownNetherlands: 660 citing papers, 3.1% of this breakdownJapan: 570 citing papers, 2.6% of this breakdownSwitzerland: 512 citing papers, 2.4% of this breakdownFrance: 491 citing papers, 2.3% of this breakdown
0%27.3%Other 24.7%

Institutions

Fields

  • Medicine61.3%
  • Neuroscience13.4%
  • Psychology10.5%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Health Professions2%
  • Computer Science1%
  • Other3.9%

Topics

  • Schizophrenia research and treatment15.4%
  • Bipolar Disorder and Treatment4.5%
  • Tryptophan and brain disorders3.4%
  • Mental Health and Psychiatry3%
  • Functional Brain Connectivity Studies2.8%
  • Treatment of Major Depression2.7%
  • Other68.2%

Coauthors

All papers

Open in search
  1. Objective User Engagement With Mental Health Apps: Systematic Search and Panel-Based Usage Analysis

    Authors: Amit Baumel, Frederick Muench, Stav Edan, John M. Kane - Journal of Medical Internet Research 2019 cited by 1,008

  2. Schizophrenia

    Authors: René S. Kahn, Iris E. Sommer, Robin Murray, Andreas Meyer‐Lindenberg, Daniel R. Weinberger, Tyrone D. Cannon, Michael O‘Donovan, Christoph U. Correll, John M. Kane, Jim van Os, Thomas R. Insel - Nature Reviews Disease Primers 2015 cited by 1,114

  3. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    Authors: Oliver Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, Michael Bloomfield, Rodrigo A. Bressan, Robert W. Buchanan, William T. Carpenter, David Castle, Leslie Citrome, Zafiris J. Daskalakis, Michael Davidson, Richard Drake, Serdar Dursun, Bjørn H. Ebdrup, Hélio Elkis, Peter Falkai, W. Wolfgang Fleischacker, Ary Gadelha, Fiona Gaughran, Birte Glenthøj, Ariel Graff‐Guerrero, Jorge Hallak, William G. Honer, James L. Kennedy, Bruce J. Kinon, Stephen M. Lawrie, Jimmy Lee, F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 cited by 1,106

  4. Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

    Authors: Nancy C. Andreasen, William T. Carpenter, John M. Kane, Robert Lasser, Stephen R. Marder, Daniel R. Weinberger - American Journal of Psychiatry 2005 cited by 2,336

  5. The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

    Authors: Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean‐Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson, Oliver Howes - FOCUS The Journal of Lifelong Learning in Psychiatry 2020 cited by 356

  6. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Authors: José de León, Georgios Schoretsanitis, Robert L. Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, I. Cánovas Olmos, Carina Ricciardi, Celso Iglesias García, Ana Iglesias-Alonso, Edoardo Spina, Can‐Jun Ruan, Chuanyue Wang, Gang Wang, Yi‐lang Tang, Shih‐Ku Lin, Hsien‐Yuan Lane, Yong Sik Kim, Se Hyun Kim, Anto P. Rajkumar, Dinora F. González‐Esquivel, Helgi Jung–Cook, Trino Baptista, Christopher Rohde, Jimmi Nielsen, Hélène Verdoux, Clélia Quilès, Emílio J. Sanz, Carlos De las Cuevas, Dan Cohen, Peter F.J. Schulte, Aygün Ertuğrul, A. Elif Anıl Yağcıoğlu, Nitin Chopra, Betsy McCollum, Charles Shelton, Robert O. Cotes, Arun R. Kaithi, John M. Kane, Saeed Farooq, Chee H. Ng, John Bilbily, Christoph Hiemke, Carlos López‐Jaramillo, Ian R. McGrane, Fernando Lana, Chin B. Eap, Manuel Arrojo, Flavian Ștefan Rădulescu, Erich Seifritz, Susanna Every‐Palmer, Chad Bousman, Emmanuel Bebawi, Rahul Bhattacharya, Deanna L. Kelly, Yuji Otsuka, Judit Lazáry, Rafael Torres, Agustín Yécora, Mariano Motuca, Sherry Kit Wa Chan, Monica Zolezzi, Sami Ouanes, Domenico De Berardis, Sandeep Grover, Ric M. Procyshyn, Richard A. Adebayo, О.О. Кирилочев, A. G. Soloviev, Konstantinos Ν. Fountoulakis, Alina Wilkowska, Wiesław Jerzy Cubała, Muhammad Ayub, Alzira Silva, Raphael M. Bonelli, José María Villagrán Moreno, Benedicto Crespo‐Facorro, Henk Temmingh, Eric Decloedt, Maria Rosel Pedro, Hiroyoshi Takeuchi, Masaru Tsukahara, Gerhard Gründer, Marina Šagud, Andreja Čelofiga, Dragana Ignjatović Ristić, Bruno Bertolucci Ortiz, Hélio Elkis, António Pacheco Palha, Adrián LLerena, Emilio Fernández-Egea, Dan Siskind, Abraham Weizman, R. Masmoudi, Shamin Mohd Saffian, Jonathan G. Leung, P.F. Buckley, Stephen R. Marder and 4 more - Pharmacopsychiatry 2021 cited by 259

  7. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis

    Authors: Christoph U. Correll, Britta Galling, Aditya Pawar, Anastasia Krivko, Chiara Bonetto, Mirella Ruggeri, Tom Craig, Merete Nordentoft, Vinod H. Srihari, Sinan Gülöksüz, Christy Lai Ming Hui, Eric Chen, Marcelo Valencia, Francisco Juárez, Delbert G. Robinson, Nina R. Schooler, Mary F. Brunette, Kim T. Mueser, Robert A. Rosenheck, Patricia Marcy, Jean Addington, Sue E. Estroff, James Robinson, David L. Penn, Joanne B. Severe, John M. Kane - JAMA Psychiatry 2018 cited by 801

  8. Clozapine for the Treatment-Resistant Schizophrenic

    Authors: John M. Kane - Archives of General Psychiatry 1988 cited by 4,135

  9. Burnout and the Quantified Workplace: Tensions around Personal Sensing Interventions for Stress in Resident Physicians

    Authors: Daniel A. Adler, Emily Tseng, Khatiya C. Moon, John Q. Young, John M. Kane, Emanuel Moss, David C. Mohr, Tanzeem Choudhury - on Human-Computer Interaction, Proc. ACM Hum. Comput. Interact. 2022 cited by 69

  10. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    Authors: Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai R. Carr, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo González, Ashley M. Holder, Jade Homsi, Vicki L. Keedy, Ciara M. Kelly, Edward Kim, David A. Liebner, Martin D. McCarter, Sean V. McGarry, Nathan W. Mesko, Christian F. Meyer, Alberto S. Pappo, Amanda Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew M. Poppe, Richard F. Riedel, Scott M. Schuetze, Jacob E. Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa N. Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman - Journal of the National Comprehensive Cancer Network 2022 cited by 1,157

  11. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Authors: Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W.J.M. Wouters, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Carlo Riccardo Rossi, Rogerio I. Neves, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Douglas B. Johnson, Patrick Terheyden, Adam C. Berger, Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 cited by 1,385

  12. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies

    Authors: Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M. Kane, Christoph U. Correll - The Lancet Psychiatry 2021 cited by 342

  13. CrossCheck: toward passive sensing and detection of mental health changes in people with schizophrenia

    Authors: Rui Wang, Min Hane Aung, Saeed Abdullah, Rachel Brian, Andrew T. Campbell, Tanzeem Choudhury, Marta Hauser, John M. Kane, Michael Merrill, Emily A. Scherer, Vincent W.-S. Tseng, Dror Ben‐Zeev - International Joint Conference on Pervasive and Ubiquitous Computing, UbiComp 2016 cited by 271

  14. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

    Authors: John M. Kane, Delbert G. Robinson, Nina R. Schooler, Kim T. Mueser, David L. Penn, Robert A. Rosenheck, Jean Addington, Mary F. Brunette, Christoph U. Correll, Sue E. Estroff, Patricia Marcy, James Robinson, Piper Meyer-Kalos, Jennifer D. Gottlieb, Shirley M. Glynn, David Lynde, Ronny Pipes, Benji T. Kurian, Alexander L. Miller, Susan T. Azrin, Amy B. Goldstein, Joanne B. Severe, Haiqun Lin, Kyaw Sint, Majnu John, Robert Heinssen - American Journal of Psychiatry 2015 cited by 850

  15. Improving outcomes of first‐episode psychosis: an overview

    Authors: Paolo Fusar‐Poli, Patrick D. McGorry, John M. Kane - World Psychiatry 2017 cited by 561

  16. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents

    Authors: Christoph U. Correll, Marco Solmi, Samuele Cortese, Maurizio Fava, Mikkel Højlund, Helena C. Kraemer, Roger S. McIntyre, Daniel S. Pine, Lon S. Schneider, John M. Kane - World Psychiatry 2023 cited by 107

  17. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

    Authors: John M. Kane, Taishiro Kishimoto, Christoph U. Correll - World Psychiatry 2013 cited by 513

  18. Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial

    Authors: John H. Krystal, John M. Kane, Christoph U. Correll, David P. Walling, Matthew Leoni, Sridhar Duvvuri, Shrinal Patel, Ih Chang, Philip Iredale, Lillian Frohlich, Stacey Versavel, Pamela Perry, Raymond Sanchez, John J. Renger - The Lancet 2022 cited by 109

  19. What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?

    Authors: Christoph U. Correll, José M. Rubio, John M. Kane - World Psychiatry 2018 cited by 319

  20. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature

    Authors: Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, William T. Carpenter, Lynn E. DeLisi, Wolfgang Gäebel, Michael F. Green, Raquel E. Gur, Stephan Heckers, John M. Kane, Dolores Malaspina, Andreas Meyer‐Lindenberg, Robin Murray, Michael J. Owen, Jordan W. Smoller, Walid Yassin, Matcheri S. Keshavan - Schizophrenia Research 2023 cited by 171

  21. Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia

    Authors: John M. Kane, Ofer Agid, Marjorie L. Baldwin, Oliver Howes, Jean-Pierre Lindenmayer, Stephen R. Marder, Mark Olfson, Steven G. Potkin, Christoph U. Correll - The Journal of Clinical Psychiatry 2019 cited by 329

  22. Dynamic Buffer Cache Management Scheme Based on Simple and Aggressive Prefetching

    Authors: Christoph U. Correll, José M. Rubio, Gabriella Inczédy-Farkas, Michael L. Birnbaum, John M. Kane, Stefan Leucht - JAMA Psychiatry, Annual Linux Showcase & Conference 2000 cited by 211

  23. Clinical implications of Brief Psychiatric Rating Scale scores

    Authors: Stefan Leucht, John M. Kane, Werner Kissling, Johannes Hamann, Eva Etschel, Rolf R. Engel - The British Journal of Psychiatry 2005 cited by 892

  24. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia

    Authors: Christoph U. Correll, Leslie Citrome, Peter Haddad, John Lauriello, Mark Olfson, Stephen M Calloway, John M. Kane - The Journal of Clinical Psychiatry 2016 cited by 367